Critical Survey: Encompass Health (NYSE:EHC) versus Basel Medical Group (NASDAQ:BMGL)

Basel Medical Group (NASDAQ:BMGL) and Encompass Health (NYSE:EHC) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.

Risk & Volatility

Basel Medical Group has a beta of 0.24, meaning that its share price is 76% less volatile than the S&P 500. Comparatively, Encompass Health has a beta of 0.72, meaning that its share price is 28% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Basel Medical Group and Encompass Health, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Basel Medical Group	1	0	0	0	1.00
Encompass Health	0	2	6	1	2.89

Encompass Health has a consensus price target of $148.71, suggesting a potential upside of 19.13%. Given Encompass Health’s stronger consensus rating and higher probable upside, analysts clearly believe Encompass Health is more favorable than Basel Medical Group.

Institutional & Insider Ownership

97.3% of Encompass Health shares are held by institutional investors. 1.8% of Encompass Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Basel Medical Group and Encompass Health”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Basel Medical Group	$8.90 million	0.87	-$9.50 million	N/A	N/A
Encompass Health	$6.21 billion	2.00	$566.20 million	$6.14	20.33

Encompass Health has higher revenue and earnings than Basel Medical Group.

Profitability

This table compares Basel Medical Group and Encompass Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Basel Medical Group	N/A	N/A	N/A
Encompass Health	10.01%	18.08%	8.22%

Summary

Encompass Health beats Basel Medical Group on 13 of the 13 factors compared between the two stocks.

About Basel Medical Group

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.